Corteva (NYSE:CTVA) Stock Rating Upgraded by JPMorgan Chase & Co.

Corteva (NYSE:CTVA) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Tuesday, Marketbeat.com reports. The brokerage presently has a $19.00 target price on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 30.48% from the company’s previous close.

Other equities analysts also recently issued reports about the company. Oppenheimer set a $17.00 price target on Corteva in a report on Monday. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. UBS Group boosted their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 16th. Royal Bank Of Canada restated an “outperform” rating and issued a $103.00 target price on shares of Corteva in a report on Wednesday, September 16th. Finally, New Street Research set a $17.00 target price on shares of Corteva in a research report on Monday. Sixteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $67.45.

Corteva Stock Up 4.7%

Corteva stock opened at $14.56 on Tuesday. The stock has a market cap of $9.72 billion, a PE ratio of 9.64, a P/E/G ratio of 0.73 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The stock’s fifty day moving average is $74.30 and its two-hundred day moving average is $79.19. Corteva has a 1-year low of $11.74 and a 1-year high of $90.97.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the prior year, the firm posted $2.20 EPS. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts expect that Corteva will post 2.77 EPS for the current fiscal year.

Hedge Funds Weigh In On Corteva

A number of institutional investors have recently modified their holdings of the business. Wellington Management Group LLP boosted its stake in shares of Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after buying an additional 6,881,875 shares during the period. Rakuten Investment Management Inc. acquired a new position in Corteva in the 2nd quarter valued at about $9,132,000. Kingsview Wealth Management LLC purchased a new stake in Corteva during the 2nd quarter valued at approximately $1,093,000. Jupiter Topco LLC purchased a new position in shares of Corteva in the 2nd quarter valued at approximately $544,246,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Corteva in the second quarter valued at approximately $392,447,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: JPMorgan upgraded Corteva to Overweight from Neutral and set a $19 price target, implying substantial upside from recent trading levels. The firm views the post-spinoff company as undervalued. JPMorgan Upgrades Corteva to Overweight
• Positive Sentiment: KeyBanc also upgraded Corteva to Overweight following the Vylor spinoff. The second bullish rating reinforces the view that the streamlined Corteva may have better growth and valuation prospects. Corteva upgraded at KeyBanc after spinoff of Vylor
• Positive Sentiment: Options activity has surged. Investors purchased 5,408 call options, compared with typical daily volume of 856. While options flow is not a guarantee of future performance, the increase suggests stronger speculative and institutional interest in further gains.
• Positive Sentiment: Recent coverage has highlighted Corteva’s rally after the spinoff and analyst endorsements, including reports that JPMorgan sees as much as 50% upside at current valuations. Corteva Soars on JPMorgan Upgrade
• Neutral Sentiment: Corteva announced that it will release third-quarter 2026 results after the market close on November 11, followed by a webcast on November 12. The announcement provides a future catalyst but contains no new operating results. Corteva Announces Third-Quarter Earnings Date
• Negative Sentiment: One valuation analysis warned that Corteva could be overvalued after its recent advance. That concern may limit additional upside if future earnings do not support the higher valuation. Corteva Valuation Analysis

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.